Transpact Enterprises Ltd
ListedSMEEmerging SME Services · BSE
Incorporated in 2013, Maharashtra-based Transpact Enterprises Limited is a biotechnology startup focused on developing innovative and affordable solutions for specially-abled individuals. The company primarily designs, develops, and distributes the Vestibulator, a therapeutic device created to address vestibular dysfunctions. The Vestibulator is a co-patented technology of Transpact Enterprises and IRCC-IIT Bombay, and the company holds a license from the Society for Innovation and Entrepreneurship, IIT Bombay, to commercialize the product. While the design and customization of the device are handled in-house with the help of advanced software, the manufacturing process is outsourced to third-party vendors. Transpact Enterprises is dedicated to continuous innovation to enhance its offerings and improve the quality of life for its users.
Price Band
₹130
Issue Size
₹1.35 Cr
Lot Size
1000 shares
GMP
—
Est. Listing
₹130
at current GMP
Subscribed
—
Open
26 Aug 2019
Close
28 Aug 2019
Allotment
3 Sep 2019
Refund
4 Sep 2019
Demat Credit
5 Sep 2019
Listing
5 Sep 2019
Last updated 12 days ago
Live Grey Market Premium
Transpact Enterprises Ltd GMP Today
Last updated: 19 Oct 2026
Current Premium
₹00.0%
Issue Price (Upper)
₹130
Band: ₹130
Estimated Listing Price
₹130
Upper price + GMP
Lot Size
1000 shares
Min investment ₹1,30,000
Estimated Profit / Lot
₹0
1000 × ₹0
Transpact Enterprises Ltd GMP Historical Trend
GMP History
Grey Market Premium trend
—
▲ 0 today
Updated 1 minute ago
Estimated Listing Price
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | — | 0.0% | ₹130 |
| 30 Oct 2026 | — | 0.0% | ₹130 |
| 29 Oct 2026 | — | 0.0% | ₹130 |
GMP is unofficial market data. Not a guarantee of listing performance.
About Transpact Enterprises Ltd Public Issue & Market Profile
Transpact Enterprises Ltd is bringing an initial public offering (IPO) in the Emerging SME Services sector with an aggregate issue size of ₹1.35 Crores. The shares are offered at a price band of ₹130 to ₹130 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Public Issue & Pricing Context:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1000 shares (approx. ₹1,30,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Basis of Allotment & Listing Timeline:
Allotment reconciliation will be managed by Bigshare Services Pvt Ltd. Eligible allottees will receive credit of equity shares into their Demat accounts by 2019-09-05, while un-allotted funds or UPI block mandates will be released on 2019-09-04.
Frequently Asked Questions
What is Transpact Enterprises Ltd IPO GMP today?
The latest grey market premium for Transpact Enterprises Ltd IPO is ₹0, which indicates an expected listing price of ₹130.
What does Kostak Rate and Sauda mean in IPO GMP?
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
Is Grey Market Premium officially recognized?
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.